Updated:
Rosetta Capital
Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Its investment approach is global, building...
Rosetta Capital
Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Its investment approach is global, building leading healthcare companies and groundbreaking technologies. The firm's primary focus is direct secondary transactions, offering adaptable liquidity solutions to investors and corporations. It has engaged in 50+ venture investments through direct secondary transactions over more than 20 years.
General information
Firm type
Venture Capital
Year founded
2001
Location
Region
Europe
Country
United Kingdom
City
Haddenham
Corporate office
Rectory House, Haddenham, HP17 8DA, United Kingdom
Additional offices
London, United Kingdom
Principals
Jonathan Hepple
Team
Ken MacLeod
Team
Michael Forer
Team
Matthew James
Team
Donovan Leung
Team
Melissa Riachi
Team
Sector focus
Frequently asked questions
How does Rosetta source its deals?
The firm sources proprietary secondary opportunities from European and North American healthcare investors and corporates looking to divest part or all of an investment. This route makes each transaction bilateral and negotiated, rather than coming through a broad intermediary auction, though Rosetta does not disclose specific sourcing partnerships.
Which sectors does Rosetta specifically target for investment?
The firm invests exclusively in the life sciences and medical device sectors. Its portfolio spans biologics, small-molecule therapeutics, drug delivery, specialty pharma and medtech, with disclosed names including Immunocore, Mission Therapeutics and JenaValve.
Does Rosetta participate in fund commitments or only direct deals?
Rosetta's activity is centered on direct secondary transactions in individual companies, not on buying limited-partner fund interests. Public materials do not indicate any separate fund-of-funds or primary LP commitment program.
Where is Rosetta Capital's presence outside the UK?
While its registered offices are in Oxford and London, the firm's investment horizon is global, with a stated track record of executing transactions across North America and Europe. No additional office locations are disclosed.
What is Rosetta Capital's known posture on co-investing alongside external GPs?
The firm makes direct secondary purchases and joins follow-on rounds, placing it alongside existing co-investors and management teams. Rosetta does not market a separate co-investment program for external limited partners, operating instead as a principal investor through its own fund vehicles.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: